In addition to the use of cyclic RGD peptides to deliver siRNA, GE11 peptide is also used, which is an anti-EGFR peptide that can actively bind to TNBC cells overexpressing epidermal growth factor receptor (EGFR), which is beneficial for siRNA to better target these tumor cells (92). Here, EGFR is linked to neoplasm.